Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells

Fig. 1

Flow cytometry of the binding potential of Peptide-FITC conjugates for target cells. P4-, P6- and P8-FITC conjugates were incubated at 0, 4 or 8 µM with 106 A20 cells and analyzed for peptide binding. P4 and P8 peptides demonstrated a strong dose-dependent binding to the target A20 cells. These peptides were then tested for binding specificity by exposure to a series of off-target cells as shown in Fig. 3

Back to article page